{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:06:56Z","timestamp":1793318816260,"version":"4.5.0"},"reference-count":77,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2025\/03\/32295"],"award-info":[{"award-number":["PSAU\/2025\/03\/32295"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Benign prostatic hyperplasia (BPH) is a multifactorial condition that is highly prevalent and affects aging males. It frequently results in lower urinary tract symptoms (LUTS) and a reduced quality of life. While hormonal dysregulation and chronic inflammation have long been implicated in BPH pathogenesis, recent evidence highlights the role of physical activity in modulating prostate health. In this narrative review, evidence from quantitative studies examining the effect of exercise on BPH risk and symptom severity was first synthesized. Collectively, these studies suggest that regular physical activity is associated with a lower incidence and reduced progression of BPH. The potential mechanisms through which exercise may exert protective effects on the prostate were then explored. These include modulation of sympathetic nervous system activity, alterations in hormonal profiles (e.g., testosterone and insulin), suppression of chronic inflammation and oxidative stress, and the promotion of autophagy within prostatic tissue. Central to these mechanisms is the role of myokines\u2014signaling molecules secreted by skeletal muscle during exercise. Key myokines, such as irisin, interleukin-6 (IL-6), brain-derived neurotrophic factor (BDNF), and myostatin, are reviewed in the context of prostate health. These molecules regulate inflammatory pathways, metabolic processes, and tissue remodeling. For instance, exercise-induced reductions in myostatin are linked to improved insulin sensitivity and decreased fat accumulation, while elevated irisin and BDNF levels may exert anti-inflammatory and metabolic benefits relevant to BPH pathophysiology. Although direct causal evidence linking myokines to BPH is still emerging, their biological plausibility and observed systemic effects suggest a promising avenue for non-pharmacological intervention. Future research should focus on identifying the specific myokines involved, elucidating their molecular mechanisms within the prostate, and evaluating their therapeutic potential in clinical trials.<\/jats:p>","DOI":"10.3390\/medicina61081362","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T07:57:24Z","timestamp":1753689444000},"page":"1362","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modulating Benign Prostatic Hyperplasia Through Physical Activity\u2014The Emerging Role of Myokines: A Narrative Review"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-8052","authenticated-orcid":false,"given":"Saad","family":"Alshahrani","sequence":"first","affiliation":[{"name":"Department of Surgery, Division of Urology, College of Medicine, Prince Sattam bin Abdulaziz University, Alkharj 11942, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lee, S.W.H., Chan, E.M.C., and Lai, Y.K. (2017). The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-06628-8"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2666-7568(22)00213-6","article-title":"The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"3","author":"Awedew","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ye, Z., Wang, J., Xiao, Y., Luo, J., Xu, L., and Chen, Z. (2024). Global burden of benign prostatic hyperplasia in males aged 60\u201390 years from 1990 to 2019: Results from the global burden of disease study 2019. BMC Urol., 24.","DOI":"10.1186\/s12894-024-01582-w"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000496289","article-title":"Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: A mini-review","volume":"65","author":"Madersbacher","year":"2019","journal-title":"Gerontology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5483\/BMBRep.2023-0064","article-title":"The role of myokines in cancer: Crosstalk between skeletal muscle and tumor","volume":"56","author":"Park","year":"2023","journal-title":"BMB Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1249\/JES.0000000000000323","article-title":"Exercise mediates myokine release and tumor suppression in prostate cancer independent of androgen signaling","volume":"51","author":"Kim","year":"2023","journal-title":"Exerc. Sport Sci. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12020-017-1476-1","article-title":"Irisin in metabolic diseases","volume":"59","author":"Polyzos","year":"2018","journal-title":"Endocrine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1249\/MSS.0b013e3181e0b9a8","article-title":"Myostatin decreases with aerobic exercise and associates with insulin resistance","volume":"42","author":"Hittel","year":"2010","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2015.02.008","article-title":"Skeletal muscle as an endocrine organ: PGC-1\u03b1, myokines and exercise","volume":"80","author":"Schnyder","year":"2015","journal-title":"Bone"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1152\/japplphysiol.00164.2004","article-title":"The anti-inflammatory effect of exercise","volume":"98","author":"Petersen","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s12967-022-03722-y","article-title":"Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: A univariable and multivariable Mendelian randomization study","volume":"20","author":"Wang","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"glad187","DOI":"10.1093\/gerona\/glad187","article-title":"Causal associations between lifestyle habits and risk of benign prostatic hyperplasia: A two-sample mendelian randomization study","volume":"79","author":"Jia","year":"2024","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3810\/psm.2009.12.1745","article-title":"Review of exercise and the risk of benign prostatic hyperplasia","volume":"37","author":"Sea","year":"2009","journal-title":"Physician Sportsmed."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.eururo.2008.02.019","article-title":"Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms","volume":"53","author":"Parsons","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15857\/ksep.2019.28.1.3","article-title":"Association of exercise with benign prostatic hyperplasia and lower urinary tract symptoms","volume":"28","author":"Lee","year":"2019","journal-title":"Exerc. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/13685538.2018.1434772","article-title":"Epidemiology and risk factors of lower urinary tract symptoms\/benign prostatic hyperplasia and erectile dysfunction","volume":"22","author":"Calogero","year":"2019","journal-title":"Aging Male"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/JU.0000000000003738","article-title":"Serum testosterone and dihydrotestosterone and incidence and progression of lower urinary tract symptoms: Results from the REDUCE study","volume":"211","author":"Daniels","year":"2023","journal-title":"J. Urol."},{"key":"ref_18","first-page":"205","article-title":"The etiology and pathogenesis of benign prostatic hyperplasia: The roles of sex hormones and anatomy","volume":"16","author":"Xu","year":"2024","journal-title":"Res. Rep. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1016\/S2666-7568(22)00243-4","article-title":"Benign prostatic hyperplasia: A global challenge of the ageing population","volume":"3","author":"Sayegh","year":"2022","journal-title":"Lancet Healthy Longev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Russo, G.I., Broggi, G., Cocci, A., Capogrosso, P., Falcone, M., Sokolakis, I., G\u00fcl, M., Caltabiano, R., and Di Mauro, M. (2021). Relationship between dietary patterns with benign prostatic hyperplasia and erectile dysfunction: A collaborative review. Nutrients, 13.","DOI":"10.3390\/nu13114148"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ye, Y., Lin, H., Wan, M., Qiu, P., Xia, R., He, J., Tao, J., Chen, L., and Zheng, G. (2021). The effects of aerobic exercise on oxidative stress in older adults: A systematic review and meta-analysis. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.701151"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Khan, S., Wolin, K., Pakpahan, R., Grubb, R., Colditz, G., Ragard, L., Mabie, J., Breyer, B., Andriole, G., and Sutcliffe, S. (2021). Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia. BMC Urol., 21.","DOI":"10.1186\/s12894-021-00816-5"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Cai, T., Ceccato, T., Botti, S., Kranz, J., Verze, P., Bonkat, G., Aversa, A., Racanelli, V., and Johansen, T.E.B. (2025). Impact of Lifestyle and the Microbiome on Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Eur. Urol. Focus.","DOI":"10.1016\/j.euf.2025.04.013"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.12688\/f1000research.160099.1","article-title":"Innovative approaches to benign prostatic hyperplasia management: Options beyond conventional treatment strategies","volume":"13","author":"Agu","year":"2024","journal-title":"F1000Research"},{"key":"ref_25","first-page":"e51314","article-title":"Pharmacological approaches in managing symptomatic relief of benign prostatic hyperplasia: A comprehensive review","volume":"15","author":"White","year":"2023","journal-title":"Cureus"},{"key":"ref_26","first-page":"770","article-title":"Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy","volume":"28","author":"Mantica","year":"2007","journal-title":"Contemp. Clin. Trials"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1111\/jocn.16749","article-title":"Non-pharmacological and nonsurgical interventions in male urinary incontinence: A scoping review","volume":"32","author":"Zhang","year":"2023","journal-title":"J. Clin. Nurs."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4082\/kjfm.2017.38.3.111","article-title":"Physical inactivity, sedentary behavior and chronic diseases","volume":"38","author":"Fuentes","year":"2017","journal-title":"Korean J. Fam. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1123\/jpah.2019-0377","article-title":"Sedentary behavior and chronic disease: Mechanisms and future directions","volume":"17","author":"Dempsey","year":"2020","journal-title":"J. Phys. Act. Health"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rus, M., Crisan, S., Andronie-Cioara, F.L., Indries, M., Marian, P., Pobirci, O.L., and Ardelean, A.I. (2023). Prevalence and risk factors of metabolic syndrome: A prospective study on cardiovascular health. Medicina, 59.","DOI":"10.20944\/preprints202308.1773.v1"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111152","DOI":"10.1016\/j.exger.2020.111152","article-title":"Aerobic exercise ameliorates benign prostatic hyperplasia in obese mice through downregulating the AR\/androgen\/PI3K\/AKT signaling pathway","volume":"143","author":"Wang","year":"2021","journal-title":"Exp. Gerontol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Eidelberg, A., Cho, A., and Chughtai, B. (2021). Effects of exercise on benign prostatic hyperplasia, lower urinary tract symptoms, and erectile dysfunction. Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia, Elsevier.","DOI":"10.1016\/B978-0-12-819765-3.00015-7"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.prnil.2022.06.004","article-title":"Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets","volume":"10","author":"Nagakura","year":"2022","journal-title":"Prostate Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/bco2.237","article-title":"The influence of lifestyle changes (diet, exercise and stress reduction) on prostate cancer tumour biology and patient outcomes: A systematic review","volume":"4","author":"Dovey","year":"2023","journal-title":"BJUI Compass"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.juro.2006.11.065","article-title":"Race\/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial","volume":"177","author":"Kristal","year":"2007","journal-title":"J. Urol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/ijc.21668","article-title":"Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia","volume":"118","author":"Zucchetto","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ije\/30.2.341","article-title":"Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China","volume":"30","author":"Lacey","year":"2001","journal-title":"Int. J. Epidemiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.158.21.2349","article-title":"Physical activity and benign prostatic hyperplasia","volume":"158","author":"Platz","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0895-4356(01)00351-1","article-title":"Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men","volume":"54","author":"Meigs","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000049871","article-title":"Life-style in patients with LUTS suggestive of BPH","volume":"40","author":"Prezioso","year":"2001","journal-title":"Eur. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/aje\/kwg051","article-title":"Risk factors for lower urinary tract symptoms in a population-based sample of African-American men","volume":"157","author":"Joseph","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2005.05571.x","article-title":"Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: Findings from the third National Health And Nutrition Examination Survey","volume":"96","author":"Rohrmann","year":"2005","journal-title":"BJU Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000089729","article-title":"Risk factors for benign prostatic hyperplasia in South Korean men","volume":"76","author":"Hong","year":"2006","journal-title":"Urol. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1249\/MSS.0b013e31817b8eba","article-title":"Effects of running distance and performance on incident benign prostatic hyperplasia","volume":"40","author":"Williams","year":"2008","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/CEJ.0b013e3282f5221e","article-title":"Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia","volume":"17","author":"Lagiou","year":"2008","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5213\/inj.2014.18.3.155","article-title":"The study about physical activity for subjects with prevention of benign prostate hyperplasia","volume":"18","author":"Lee","year":"2014","journal-title":"Int. Neurourol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1249\/MSS.0000000000000444","article-title":"Physical activity and benign prostatic hyperplasia-related outcomes and nocturia","volume":"47","author":"Wolin","year":"2015","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Yoosuf, B.T., Panda, A.K., Kt, M.F., Bharti, S.K., Devana, S.K., and Bansal, D. (2024). Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: A systematic review and network meta-analysis. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-61977-5"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.ju.0000173072.73702.64","article-title":"Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"174","author":"McVary","year":"2005","journal-title":"J. Urol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1016\/j.neuron.2022.10.017","article-title":"The sympathetic nervous system in the 21st century: Neuroimmune interactions in metabolic homeostasis and obesity","volume":"110","author":"Sweeney","year":"2022","journal-title":"Neuron"},{"key":"ref_51","first-page":"14186","article-title":"The Relationship of Insulin Resistance With some Proinflammtory markers In Prostate Cancer and Benign Prostate Hyperplasia Patients","volume":"25","author":"Ati","year":"2021","journal-title":"Ann. Rom. Soc. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Daniela, M., Catalina, L., Ilie, O., Paula, M., Daniel-Andrei, I., and Ioana, B. (2022). Effects of exercise training on the autonomic nervous system with a focus on anti-inflammatory and antioxidants effects. Antioxidants, 11.","DOI":"10.3390\/antiox11020350"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","article-title":"Metabolic syndrome","volume":"10","author":"Neeland","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"123192","DOI":"10.1016\/j.lfs.2024.123192","article-title":"Association between metabolic syndrome and benign prostatic hyperplasia: The underlying molecular connection","volume":"358","author":"Fu","year":"2024","journal-title":"Life Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/mmj.mmj_166_19","article-title":"Correlation between metabolic syndrome and benign prostatic hyperplasia","volume":"34","author":"Attia","year":"2021","journal-title":"Menoufia Med. J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Daher, M., Saqer, T., Jabr, M., and Al-Mousa, S. (2023). Benign prostatic hyperplasia and metabolic syndrome; prevalence and association: A cross-sectional study in Syria. BMC Urol., 23.","DOI":"10.1186\/s12894-023-01365-9"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"384","DOI":"10.21037\/tau-20-1127","article-title":"The association between metabolic syndrome and lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males: Evidence based on propensity score matching","volume":"10","author":"Xiong","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/pros.21041","article-title":"Increased cell proliferation and contractility of prostate in insulin resistant rats: Linking hyperinsulinemia with benign prostate hyperplasia","volume":"70","author":"Vikram","year":"2010","journal-title":"Prostate"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2010.05.042","article-title":"Insulin-resistance and benign prostatic hyperplasia: The connection","volume":"641","author":"Vikram","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.diff.2011.04.004","article-title":"Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia","volume":"82","author":"Wang","year":"2011","journal-title":"Differentiation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ajur.2019.10.003","article-title":"The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review","volume":"7","author":"Vickman","year":"2020","journal-title":"Asian J. Urol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101711","DOI":"10.1016\/j.cont.2024.101711","article-title":"Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia (BPH): A historical perspective","volume":"12","author":"Diokno","year":"2024","journal-title":"Continence"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Oseni, S.O., Naar, C., Pavlovi\u0107, M., Asghar, W., Hartmann, J.X., Fields, G.B., Esiobu, N., and Kumi-Diaka, J. (2023). The molecular basis and clinical consequences of chronic inflammation in prostatic diseases: Prostatitis, benign prostatic hyperplasia, and prostate cancer. Cancers, 15.","DOI":"10.3390\/cancers15123110"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/aje\/kwj258","article-title":"Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia","volume":"164","author":"Jacobson","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1464-410X.2010.09598.x","article-title":"Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms","volume":"107","author":"Jacobsen","year":"2011","journal-title":"BJU Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1464-410X.2012.11559.x","article-title":"Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: Systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Kahokehr","year":"2013","journal-title":"BJU Int."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Peng, Z.-H., Li, M.-R., He, M.-X., Liu, J., Dou, J.-H., Wang, Y.-W., Dong, Y., Yan, C., Li, Z.-H., and Chong, T. (2025). Causal association between non-steroidal anti-inflammatory drugs use and the risk of benign prostatic hyperplasia: A univariable and multivariable Mendelian randomization study. BMC Med. Genom., 18.","DOI":"10.1186\/s12920-025-02128-1"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4111\/kju.2012.53.5.335","article-title":"Is high-sensitivity C-reactive protein associated with lower urinary tract symptoms in aging men? Results from the hallym aging study","volume":"53","author":"Choi","year":"2012","journal-title":"Korean J. Urol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","article-title":"The relationship between prostate inflammation and lower urinary tract symptoms: Examination of baseline data from the REDUCE trial","volume":"54","author":"Nickel","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/pr.112.007120","article-title":"Therapeutic targeting of autophagy in disease: Biology and pharmacology","volume":"65","author":"Cheng","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3892\/br.2013.171","article-title":"Roles of autophagy-related genes Beclin-1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia","volume":"1","author":"Liu","year":"2013","journal-title":"Biomed. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9718","DOI":"10.18632\/oncotarget.3929","article-title":"Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats","volume":"6","author":"Lesovaya","year":"2015","journal-title":"Oncotarget"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12576-016-0440-9","article-title":"Autophagy plays a role in skeletal muscle mitochondrial biogenesis in an endurance exercise-trained condition","volume":"66","author":"Ju","year":"2016","journal-title":"J. Physiol. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle\u2013organ crosstalk: The emerging roles of myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/jcp.30033","article-title":"Myokines mediate the cross talk between skeletal muscle and other organs","volume":"236","author":"Chen","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e2544","DOI":"10.1002\/brb3.2544","article-title":"The effect of physical exercise on circulating brain-derived neurotrophic factor in healthy subjects: A meta-analysis of randomized controlled trials","volume":"12","author":"Wang","year":"2022","journal-title":"Brain Behav."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch. Med. Sci."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1362\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:06Z","timestamp":1760033826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":77,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081362"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081362","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}